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ABSTRACT
Variable Modulation of Inputs to GABA Cells in the
Ventral Tegmental Area and Hippocampus
Teresa Marie Nufer
Neuroscience Center, BYU
Doctor of Philosophy
The ventral tegmental area (VTA) is an important component of the mesolimbic
dopamine circuit and processes reward and motivational behaviors. In response to drug exposure,
synaptic connections of this circuit can be rewired via synaptic plasticity—a phenomenon
thought to be responsible for the pathology of addiction. While much is known about dopamine
neuron plasticity, less is known regarding plasticity exhibited by VTA GABA cells, specifically
inhibitory inputs from outside the VTA. Expanding on the work of Bocklisch et al. (2013), we
investigated the plasticity of inhibitory inputs to VTA GABA neurons. Using whole cell
electrophysiology in GAD67 GFP mice, we observed that these VTA GABA cells can
experience either long-term potentiation (LTP) or long-term depression (LTD) in response to a 5
Hz stimulus. While neither the LTP nor LTD appear to be mediated by the cannabinoid-1
receptor (CB1), the nitric oxide synthase (NOS) pathway, or the dopamine-2 (D2) receptor, the
LTP is blocked by APV, an NMDA receptor antagonist, and the LTD is blocked by CGP 54626,
an antagonist of the GABAB receptor. Additionally, µ-opioid and adenosine-1 receptors
modulated plasticity at this synapse, but chronic morphine administration (10mg/kg) did not
block the observed LTP or LTD. Furthermore, we used an optogenetic approach in VGAT-Cre
mice to target inhibitory inputs from the lateral hypothalamus (LH) to the VTA. An optical
stimulus (5 Hz) caused these inputs to depress, which has not been previously described and may
be behaviorally important in reward processing. These novel findings increase our understanding
of VTA neural circuitry, ultimately increasing our capacity to better comprehend and treat the
pathology of addiction.
Additionally, changes in synaptic strength in hippocampal CA1 pyramidal cells are
thought to be responsible for the acquisition and retention of short-term memory. Feedforward
stratum radiatum interneurons of many subtypes experience LTD, short-term depression (STD),
or lack of plasticity, but it is not known whether plasticity correlates with specific interneuron
subtypes. Using whole cell electrophysiology and qPCR, we characterized the plasticity
expressed by hippocampal interneurons in correlation with their mRNA expression patterns to
determine cell subtype. We also assessed the expression of endocannabinoid (eCB) biosynthetic
enzymes as well as metabotropic glutamate receptor subunits known to mediate plasticity. Cells
exhibiting LTD tended to express mRNA for at least one of the eCB biosynthetic enzymes and
the metabotropic glutamate receptor subunit mGluR5. mGluR5 was not expressed by cells
exhibiting STD or no plasticity. Cells that exhibited short-term depression tended to express
mRNA for at least one of the eCB biosynthetic enzymes, but not mGluR5. This suggests that
stratum radiatum interneuron plasticity can be predicted based on mGluR expression, and that
these different types of plasticity may have some importance in hippocampal function.
Keywords: GABA, long-term depression, long-term potentiation, addiction, radiatum, mGluR5
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CHAPTER 1: Introduction
The mammalian brain contains billions of neurons and trillions of synapses—allowing
for nearly infinite possibilities in their connectivity. Most neurons in the brain receive input from
hundreds of other neurons and send their output to many hundreds of others. Changes to the
brain in response to the environmental stimuli and other conditions happen on a molecular level
through changes at neural synapses. The brain’s ability to remodel synapses in response to
environmental cues is termed "use dependence" or neural plasticity.
Laboratory studies of rodent brain slices in vitro have revealed the phenomena of longterm potentiation (LTP) and long-term depression (LTD). LTP involves strengthening a synapse
and classically occurs in response to higher frequency stimulus (Bliss & Lomo, 1973), whereas
LTD weakens a synapse and traditionally occurs in response to lower frequency stimulus (Dudek
& Bear, 1992). While LTP and LTD are both laboratory phenomena, many studies show that
similar mechanisms occur in vivo and behaviorally modulate learning and memory (Mayford et
al., 1996; Tsien et al., 1996; Tang et al., 1999). Hence, in many brain areas including the
hippocampus, LTP-like mechanisms are most likely associated with “remembering” or
“learning,” and LTD-like mechanisms are probably linked to “forgetting” (Malenka & Bear,
2004). Recently, LTD has also been reported as a process of synaptic refinement and memory
consolidation (Draguhn, 2018).
Synaptic transmission consists of presynaptic release of neurotransmitter from the axon
terminal of one cell combined with postsynaptic activation of receptors by that neurotransmitter
on another cell. Strengthening a synapse means that signals passing through that synapse are
amplified. This can be accomplished by releasing more vesicles of neurotransmitter from the
presynaptic terminal, or by increasing the number of receptors on the postsynaptic terminal.
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Many times, both presynaptic and postsynaptic mechanisms in concert contribute to synaptic
strengthening or weakening (Malenka & Bear, 2004). Some types of LTP may even involve the
formation of new dendritic spines and new synapses between neurons. Thus, on the cellular
level, remembering and learning are experience-directed changes in synaptic strength. Learning a
new skill or fact results in the modification of synapses at any number of locations in the brain
(Malenka & Bear, 2004). Researchers generally accept these molecular-level changes to be the
basis for learning and memory in brain areas such as the hippocampus, cortex, and cerebellum.
LTP and LTD can also modulate behavior in other brain areas including goal-directed behavior
in the ventral tegmental area (VTA).
The VTA is a small, medially-located midbrain structure that houses dopamine neurons
that project to the nucleus accumbens (NAc) and release dopamine when activated (Berridge &
Robinson, 1998). Dopamine release is involved in associative learning of reward and is
important for identifying species-perpetuating activities like eating and mating. Hence, eating
and sex are pleasurable activities and involve the release of dopamine in NAc by neurons
projecting from the VTA (Fields et al., 2007). The pleasurable “thumbs-up” signal associated
with eating, drinking, finding shelter, or mating is important for the perpetuation and survival of
the species; thus, the mesolimbic dopamine system is an evolutionarily “old” brain structure that
is conserved throughout most vertebrate species (Prakash & Wurst, 2006). Dopamine signaling
from the VTA is a key component in reward learning (Tsai et al., 2009).
Recent evidence points to VTA dopamine neurons as a target of illicit drugs such as
opiates, methamphetamine, tetrahydrocannabinol (THC), cocaine, nicotine, ethanol,
benzodiazepines, and other addictive substances (Lüscher and Ungless, 2006). These substances
artificially induce excessive dopamine release during their administration but leave lasting
2

consequences for their users. Drug users can no longer process reward normally and experience
withdrawals, cravings, and deterioration of executive function in both the acute and chronic
phases of addiction.
Addiction is now widely recognized as a brain disorder involving the rewiring of the
brain regions that process reward. Whether a person struggles with a gambling addiction or a
cocaine addiction, satisfying his addiction becomes paramount to all other needs, desires, and
responsibilities, in spite of negative consequences. Individuals suffer personal consequences such
as strained family relations and employment instability. Society pays billions of dollars every
year to help treat addiction and manage its consequences. Indeed, addiction is a severe
neuropsychological disorder that requires further investigation. According to Koob and Le
Moal, there are three parts of the cycle of addiction: binge/intoxication, withdrawal/negative
affect, and preoccupation/anticipation (2001). As a person passes through these “stages” of
addiction again and again, the hedonic potential of the drug decreases. That is, after every
binge/intoxication episode, the “high” that the user receives diminishes somewhat as compared
to the previous episode. The subsequent withdrawal episode is even more unpleasant than the
one before because basal dopamine firing is considerably below its normal level. The only way
that the brain knows to return dopamine levels to their former glory is to use the drug again, thus
the preoccupation/anticipation phase also becomes more intense. Overtime, the decision-making
prefrontal cortex completely goes offline, and instead hedonic mesolimbic desires drive
behavior. The substance abuser is left at the mercy of his addiction—there is no longer executive
control of “reward, pain, stress, emotion, habits, and decision-making” (George & Koob, 2010).
Hence, addicts seek out their preferred high without regard for basic physical needs, physical
pain, emotional pain, or neglected family and work responsibilities.
3

While much has been said and hypothesized about psychological theories of addiction,
the neural mechanisms of addiction in the brain were largely ambiguous until the groundbreaking work of Ungless et al. showed plasticity of dopamine neurons in the VTA following in
vivo cocaine administration to mice (2001). After a single exposure to cocaine, the animals’
brains showed a marked increase in AMPA/NMDA ratio at the glutamate to dopamine synapse
in the VTA (see Figure 1.1), while hippocampal glutamatergic and VTA GABAergic synapses
displayed no such plasticity. The cocaine-induced plasticity was sensitive to the NMDA receptor
antagonist MK-801, suggesting an NMDA-dependent mechanism. Hence, a neural model for
drug abuse and addiction was born.
However, dopamine neurons are not the only players in the neural circuitry of reward and
addiction. The VTA houses a heterogeneous population of both dopamine and GABA neurons.
Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter of the brain and will
bind to both ionotropic (GABAA) and metabotropic (GABAB) receptors, which are both
distributed ubiquitously throughout the mammalian brain (Bowery et al., 1987). Numerous
studies have shown that GABA cells synapse onto and modulate dopamine cell activity in the
VTA (Grace & Bunney, 1979; Kalivas et al., 1990; Klitenick et al., 1992; Nugent et al., 2007;
Nugent et al., 2009; Lüscher and Malenka, 2011; Edwards et al., 2017; see also Figure 1.1).
Many of these same studies have clearly demonstrated that drugs of abuse can also modulate
plasticity of GABAergic afferents to dopamine neurons. Nugent et al. showed that LTP of
GABA neurons was blocked by opioid administration (2007). Others have likewise demonstrated
that the “learning” and plasticity involved in addiction and drug abuse affect the firing rate of
dopaminergic neurons by altering the GABA neurons that innervate them (Liu et al., 2005).
Optical stimulation of GABA neurons can disrupt reward consumption (van Zessen et al.,
4

2012)—thus amending the dopamine hypothesis that all reward learning and addiction pathology
depends solely on only dopamine. VTA GABA neurons can also modulate reward learning in
important ways. While dopamine release is critical to motivational learning and encoding reward
prediction error (Schultz et al., 1993; Mirenowicz & Schultz, 1994; Schultz, 1998; Fiorillo et al.,
2003), actual reward is likely mediated by GABA via a dopamine-independent mechanism
(Laviolette & van der Kooy, 2001; Laviolette et al., 2004).
The functional role of VTA GABA plasticity in motivational learning, reward, and
addiction pathology requires further investigation. While we have some understanding of how
local dopamine and GABA neurons interact in the VTA, we understand very little about the
excitatory and inhibitory inputs onto VTA GABA cells. Our lab recently showed how excitatory
inputs to VTA GABA cells exhibit CB1-dependent LTD that is blocked by chronic THC
administration (Friend et al., 2017). Bocklisch et al. used an optogenetic model to demonstrate
that D1-expressing GABA projections from the NAc to VTA GABA neurons experience longterm potentiation (LTP) following a high-frequency optical stimulation (2013). This plasticity
appeared to be presynaptic and was dependent on L-type calcium channels, the D1 receptor,
activation of adenylyl cyclase, and the scaffolding protein Rim1α. The LTP they described was
occluded by chronic cocaine administration. However, questions remain about the mechanism of
plasticity at this synapse of inhibitory inputs to VTA GABA neurons.
So not only is the GABA-dopamine synapse affected by drug exposure, but the next
synapse upstream (the GABA-GABA synapse) is also affected by addictive drug exposure.
However, inhibitory inputs to the VTA do not originate solely from the NAc, but also from the
pedunculopontine tegmental nucleus, the posterior laterodorsal tegmental nucleus, the ventral
pallidum, the rostral medial tegmental nucleus, lateral hypothalamus, and the possibly other
5

brain areas (Fields et al., 2007). Perhaps these inputs exhibit plasticity that could be altered by
illicit drug exposure. To fully comprehend the pathology of addiction, we must first understand
the mechanisms of plasticity in a drug-naïve state. Second, we need to understand the effect that
addictive drugs have on each synapse of the mesolimbic dopamine system, including the
inhibitory inputs to VTA GABA cells.
Currently, molecular addiction research focuses on better understanding the complex
circuitry that controls reward learning and processing in the brain. Developing a more complete
understanding of the pathology of addiction will allow scientists to eventually discover a cure for
addiction that will (hopefully) reverse the plasticity that has occurs in response to drug
administration. There is currently no treatment for substance addictions that actually reverses the
disorder. Rehabilitation centers focus on removing individuals from people and environments
that stimulate drug-seeking and drug-taking behavior. Patients learn techniques of avoiding
situations in which they may be tempted to relapse and are taught more healthy methods of
dealing with their anxiety and stress as an alternative to drug use. Other methods of addiction
treatment are more pharmacological and instead focus on “weaning” addicts off their drug of
choice and attenuating withdrawal symptoms. This is the idea behind nicotine patches/Nicorette
gum (for nicotine addiction) and prescription drugs like methadone and buprenorphine (for
opioid addiction). Buprenophine (brand name Suboxone) is a partial µ-opioid receptor agonist
that mimics that effects of opioid administration and reduces cravings to better manage opioid
addiction recovery (Ling et al., 2013). While all these treatment options are steps in the right
direction, they are still just Band-Aids for a deeper problem—that is, permanently altered
synaptic plasticity within the mesolimbic dopamine circuit. A study of the plasticity at the
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synapse of inhibitory inputs to VTA GABA neurons is a critical component of understanding
mesolimbic dopamine circuit function.
In addition, we are also interested in GABA cell plasticity in the hippocampus. As
mentioned previously, the hippocampus is another area of the brain where plasticity occurs and
has classically been studied. The hippocampus is an area of the neocortex known to be involved
in the formation and consolidation of memory. It is organized into several layers including the
stratum radiatum, stratum pyramidale, and stratum oriens, which are in the hippocampus proper,
or cornu ammonis, an area that can be subdivided into CA1, CA2, and CA3 (Andersen et al.,
1971; Andersen et al., 2000). Each of these layers and sub-regions has specific connectivity
within the hippocampus and with its efferents and afferents (Laurberg, 1979). The stratum
pyramidale contains excitatory, glutamatergic pyramidal cells. CA1 pyramidal cells receive their
input largely from CA3 pyramidal cells and project to the subiculum and entorhinal cortex. In
general, pyramidal cells are thought to be a mostly homogenous population of cells. Both the
inputs and outputs to CA1 pyramidal cells are heavily modulated by GABAergic interneurons in
both the stratum oriens and the stratum radiatum (Ribak et al., 1986). Unlike pyramidal cells,
GABAergic interneurons of the hippocampus comprise a wildly heterogeneous population of
cells. There are many subtypes of these interneurons including, among others, parvalbumincontaining axo-axonic cells, calretinin-containing interneuron-selective cells, and
cholecystokinin/calbindin positive basket cells (Fruend & Buzaki, 1996). In 1997, McMahon &
Kauer determined that GABA cells, contrary to the expectations of the time, also exhibit neural
plasticity in response to a high frequency stimulus, similar to pyramidal cells. While radiatum
interneurons induce long-term depression (LTD), short-term depression (STD), or lack of
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plasticity (McMahon & Kauer, 1997), it is not known whether these types of plasticity correlate
to any specific interneuron subtype.
Hippocampal interneuron plasticity can be modulated by endocannabinoid activity
including activation of CB1 receptors and TRPV1 receptors (Gibson et al., 2008). Other data
show that Type 1 mGluRs may also be necessary for the modulation of interneuron plasticity (Le
Duigou et al., 2011). Surely the influence of these modulators affects the type of plasticity that a
radiatum interneuron will experience. Understanding the character of GABA neurons in the
hippocampus, specifically the CA1 stratum radiatum, may be critical to comprehending the
larger roles of GABAergic modulatory inhibition in memory formation.
As with my studies in the VTA, in the hippocampus the excitatory neurons are important,
but their constitutive activity appears to be heavily modulated by inhibitory interneurons. In both
the VTA and hippocampus, we might say that the GABA neurons are truly “running the show,”
even though historically dopamine cells in the VTA and glutamatergic pyramidal cells in the
hippocampus have been more thoroughly studied. Now we seek to better understand the function
and purpose of the VTA and hippocampus through studying inhibitory modulation of plasticity
in these brain areas.

8

Specific Aims
Understanding the molecular mechanisms of synaptic plasticity paints a clearer picture of
how synapses function in the brain and how differences between synapses change their function
and output. Our aim was to investigate the molecular mechanisms of plasticity at the synapse of
inhibitory afferents to VTA GABA cells. These cells are part of the mesolimbic dopamine
circuit, so increasing our understanding of synaptic plasticity in this circuit enhances our
knowledge of addiction as a neurological disease.
In addition, we aim to better understand the correlation of plasticity with interneuron
subtype in the CA1 stratum radiatum. This knowledge expands our comprehension of the
modulatory role of GABAergic interneurons in hippocampal memory consolidation.

9

Figure 1.1: Simplified VTA Circuitry. Ungless et al. (2001) described the synapse of glutamatergic inputs to VTA
dopamine cells (pink cells to green cells). Nugent et al. (2007) described GABAergic inputs to VTA dopamine cells
(purple cells to green cells). Bocklisch et al. described the synapse of GABAergic inputs to VTA GABA cells
(purple cells to purple cells).
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CHAPTER 2: Inhibitory Inputs to VTA GABA Neurons Exhibit LTP or LTD
Teresa Nufer, Bridget Wu, Walter St. Pierre, Brandon Anderson,
Scott Steffensen, Jeffrey Edwards
Abstract
The ventral tegmental area (VTA) is an essential component of the mesolimbic dopamine
circuit and processes reward and motivational behaviors. The VTA contains dopamine cells
thought to mediate reward as well as GABAergic inhibitory cells that can regulate dopamine cell
activity. In response to drug exposure, synaptic connections of this circuit can be rewired via
synaptic plasticity—a phenomenon thought be responsible for the pathology of addiction. While
much is known about dopamine neuron plasticity, less is known regarding plasticity exhibited by
VTA GABA cells, specifically inhibitory inputs from outside the VTA. Expanding on the work
of Bocklisch et al. (2013), we investigated the plasticity of inhibitory inputs to VTA GABA
neurons. Using whole cell electrophysiology in GAD67 GFP mice, we observed that these VTA
GABA cells can experience either long-term potentiation (LTP) or long-term depression (LTD)
in response to a 5 Hz stimulus. Paired pulse ratios suggest a presynaptic mechanism for both
types of plasticity. While neither the LTP nor LTD appear to be mediated by the cannabinoid-1
receptor (CB1), the nitric oxide synthase (NOS) pathway, or the dopamine-2 (D2) receptor, the
LTP is blocked by APV, an NMDA receptor antagonist, and the LTD is blocked by CGP 54626,
an antagonist of the GABAB receptor. Additionally, we found some cells to be depressed by the
acute application of DAMGO, a µ-opioid receptor agonist, while others were slightly
potentiated. To further investigate these pathways, we used an optogenetic approach in VGATCre mice to target inhibitory inputs from the lateral hypothalamus (LH) to the VTA. A 5 Hz
optical stimulus caused these inputs to depress. LTD at this synapse has not been previously
11

described and could be an important component of the reward processing pathway. We also
found that neither acute or chronic morphine administration (10mg/kg) occluded the observed
LTP or LTD. Additionally, these novel findings regarding the molecular mechanisms of
synaptic plasticity at this inhibitory synapse onto VTA GABA cells help us better understand
VTA neural circuitry, ultimately increasing our capacity to better understand and treat the
pathology of addiction.

12

Introduction
The mesolimbic dopamine circuit contains important, evolutionarily-conserved pathways
that normally help animals to identify and seek species-perpetuating behaviors, as well as avoid
harmful behaviors (Berridge & Robinson, 1998). Dopamine neurons in the ventral tegmental
area (VTA) project to the nucleus accumbens (NAc) where they release dopamine onto medium
spiny neurons (MSNs; Fields et al., 2007). Drugs such as opiates, amphetamines,
tetrahydrocannabinol (THC), cocaine, nicotine, ethanol, and other addictive substances
artificially increase dopamine release and/or increase its duration at the synapse and cause
persistent changes at synapses within and connecting to this mesolimbic circuit (Di Chiara &
Imperato, 1988; Lüscher and Ungless, 2006). Addiction is a brain disease involving the rewiring
of neural circuitry in response to drug exposure (Wise, 2004; Creed & Lüscher, 2013). Drug
users can no longer process reward normally and experience withdrawals, cravings, and
deterioration of executive function in both the acute and chronic phases of addiction.
Synaptic plasticity following drug exposure was initially observed in excitatory inputs to
VTA dopamine cells (Ungless et al., 2001), and drug-dependent plasticity has since been
thoroughly described at both excitatory and inhibitory inputs onto dopamine cells (Bonci &
Malenka, 1999; Saal et al., 2003; Nugent et al. 2007; Argilli et al., 2008; Stuber et al., 2008;
Zweifel et al., 2008; Nugent et al., 2009; Kodangattil et al., 2013). While the dopamine cells
involved in addiction have been thoroughly studied, research shows that the inhibitory GABA
neurons modulating those dopamine cells are also altered in addiction (Roberts et al., 1996; Liu
et al., 2005, Barrett et al., 2005). However, less is understood about the inputs to these GABA
neurons and how they change following drug exposure. Inhibitory inputs to VTA GABA neurons
come from many areas of the brain (Fields et al., 2007; Morales & Margolis, 2017), but perhaps
13

the most predominant and well-studied in recent years are from the nucleus accumbens (NAc)
and the lateral hypothalamus (LH).
The NAc is a bilaterally located nucleus in the medial forebrain composed mostly of
inhibitory medium spiny neurons (MSNs) as well as small populations of glutamatergic and
cholinergic interneurons (Yamaguchi et al., 2011; Brown et al., 2012). MSNs project back to the
VTA to inhibit both GABA and dopamine cells (Xia et al., 2011; van Zessen et al., 2012;
Edwards et al., 2017). Bocklisch et al. used an optogenetic model to demonstrate that D1expressing GABA projections from the NAc to VTA GABA neurons experience long-term
potentiation (LTP) following a high-frequency optical stimulation (2013). This plasticity
appeared to be presynaptic and was occluded by chronic cocaine administration. More recently
Edwards et al. used a Cre-driven optogenetic mouse model to discover compelling evidence that
NAc D1 MSN input to VTA GABA neurons is GABAA mediated and modulated by the
adenosine-1 receptor (2017). These NAc D1 MSN inputs to the VTA showed cocaine, but not
morphine, sensitization. We hypothesized that the NAc to VTA pathway could be influenced by
other neuromodulators beyond those already studied and aimed to confirm the LTP described by
Bocklisch et al. (2013).
The LH also provides inhibitory input to the VTA and contains many cell types including
GABA, glutamate, and neuropeptide-releasing cells (Berthoud & Munzberg, 2011). The LH has
classically been studied for its role in regulating feeding behaviors—electrical stimulation of the
LH produces voracious feeding in sated animals, while ablation of LH neurons leads to aphagia
and emaciation (Wise, 1971; Hoebel, 1965). Jennings et al. used an optogenetic model to target
specific subpopulations of LH cells and reveal the importance of LH GABA neurons in
regulating feeding behavior (2015). Additionally, the LH to VTA pathway facilitates both
14

feeding and compulsive sucrose-seeking behaviors, and stimulation of LH GABAs inhibits VTA
GABAs and increases dopamine release in the NAc (Nieh et al., 2015; Nieh et al., 2016).
Stimulating this pathway at higher or lower frequencies appears to facilitate pleasurable reward
or drive-like feeding behaviors, respectively (Barbano et al., 2016). We hypothesized that this
LH pathway may be involved in drug-induced plasticity.
We used whole cell electrophysiology ex vivo to study the modulation of inhibitory
inputs to VTA GABA neurons. We not only observed the previously reported LTP at this
synapse, but we also describe a novel form of plasticity at this synapse that has not previously
been reported—inhibitory inputs onto VTA GABA neurons can exhibit either LTP or LTD.
Interestingly, neither form of plasticity is blocked by chronic morphine administration. We
investigated the hypothesis that the observed LTP or LTD could be input-dependent, and we
found evidence for plasticity at the inhibitory LH to VTA GABA afferent using an optogenetic
model.

15

Methods
Electrophysiology
All experiments were performed in accordance with Institutional Animal Care and Use
Committee protocols and NIH guidelines for the care and use of laboratory animals. Male
GAD67 GFP (Tamamaki et al., 2003) mice P15-30 days old were anesthetized with isoflurane
(1.5-2%) and decapitated. Brains were removed and sectioned transversely on a vibratome at 300
µm using ice cold oxygenated sucrose solution composed of 220 mM sucrose, 3 mM KCl, 1.25
mM NaH2PO4, 0.2 mM CaCl2, 12 mM MgSO4, 25 mM NaHCO3, 10 mM glucose, and 400 μM
ascorbic acid. Recordings began at least one hour after cutting while tissue was stored in
oxygenated ACSF composed of 119 mM NaCl, 26 mM NaHCO3, 2.5 mM KCl, 1 mM NaH2PO4,
2.5 mM CaCl2, 1.3 mM MgSO4, and 11 mM glucose. Excitatory glutamate currents were
blocked using 10 μM CNQX (Alomone Labs) throughout. NMDA antagonist APV was not
constitutively applied because cells were constantly held in voltage clamp at -65 mV throughout
experiments. An Olympus BX51WI microscope with a 40x water immersion objective was used
to visualize the VTA, identified as a nucleus of GFP+ cells surrounding the fasiculus retroflexus.
GFP+ cells were patched with a borosilicate glass pipette (3-6 MΩ) filled with internal solution
composed of 117mM KCl, 2.8mM NaCl, 20mM HEPES, 5mM MgCl2, and 1 mM QX-314
(Tocris) with pH 7.28 and osmolarity 275–285 mOsm. Recording were made in voltage clamp
with cells being held at -65 mV throughout experiments. Plasticity was induced using a 5 Hz
stimulation in current clamp mode and delivered using a concentric bipolar electrode
(Microprobes for Life Science) 200-400 µm from the patched cell. Currents were recorded using
Multiclamp 700B amplifier and digitized with an Axon 1440A digitizer (both from Molecular
Devices, Sunnyvale, CA, USA). Signals were filtered at 4 kHz and recorded using Clampex 10.4
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(Molecular Devices) on a personal computer. Electrophysiological data was analyzed using
Clampfit software (Molecular Devices), Microsoft Excel, and Origin 10.8 (OriginLab
Corporations, Northampton, MA, USA). All p-values were obtained by a Student’s t-test
comparing the 5 minutes before conditioning to 15-25 minutes post conditioning.
Surgery and Optogenetic Manipulation
Male VGAT-Ires-Cre mice (Jackson Labs, stock# 028862) were crossed with female
GAD67 GFP+ mice. Male GFP+ cross mice older than 21 days received stereotaxic
neurosurgery in a Kopf stereotaxic apparatus (Model 940). Mice were anesthetized using 1-3%
isoflurane using a Kent SomnoSuite. Mice received carprofen tablets 24 hours before and for at
least 72 hours following surgery, as well as a subcutaneous injection of buprenorphine (0.1
mg/kg) after induction of anesthesia and immediately before surgery. Mice received bilateral
injections of AAV2/1-EF1a-DIO-hChR2(H134R)-mCherry (UNC Vector Core) in the Nucleus
Accumbens (AP +1.6, ML ±0.6, DV -4.4 to -4.5 DV) or in the Lateral Hypothalamus (AP -1.3,
ML ±0.6 to 0.8, DV -5.2 to -5.3). Animal recovery and viral incubation lasted 3-8 weeks postsurgery, after which time animals were sacrificed for experiments via the protocol previously
described. Cutting took place in either the previously described sucrose solution or in an NMDGbased solution (92 mM NMDG, 2.5 mM KCl, 1.25 mM NaH2PO4, 30 mM NaHCO3, 20 mM
HEPES, 25 mM glucose, 2 mM thiourea, 5 mM Na-ascorbate, 3 mM Na-pyruvate, 0.5 mM
CaCl2·4H2O and 10 mM MgSO4·7H2O, titrated to ~ pH 7.4 with HCl) and was proceeded by
transcranial perfusion with said solution (Pan et al., 2015). Slices were then maintained in a
HEPES holding solution (92 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 30 mM NaHCO3, 20
mM HEPES, 25 mM glucose, 2 mM thiourea, 5 mM Na-ascorbate, 3 mM Na-pyruvate, 2 mM
CaCl2·4H2O and 2 mM MgSO4·7H2O) in an incubator for at least one hour before
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electrophysiology was attempted. Blue light for optical activation was generated by a TLED+
from Sutter Instruments with individual light pulses lasting 1-2 ms.
PCR
Cells from GFP- littermates of GFP+ mice were used for PCR analysis and extracted
using gentle suction and placed into chilled reverse transcriptase reagents (BioRad) within 2
hours. One control sample of artificial cerebral spinal fluid was obtained for each slice and used
to identify contamination from extracellular mRNA. Using iScript cDNA Synthesis kit (BioRad),
extracted cells were reverse transcribed to cDNA under the manufacturer’s protocol and cycled
in a C1000 Thermocycler (BioRad) at 25°C for 8 min, 42°C for 60 min, and 70°C for 15 min.
Following reverse transcription, each cell was divided into three 5µL aliquots which each
received a different group of 10-fold diluted primers, iQ Supermix (BioRad), and ddH20. We
performed additional no-template-control tests to ensure that there were no primer dimer or
hairpin interactions between primers. The samples were cycled in a C1000 Thermocycler
(BioRad) starting at 95°C for 3 minutes, then 15 cycles of 95°C for 15 minutes, 57°C for 20
seconds, and 72°C for 25 seconds. The primer and probe sequences were those used in our
previous study (Merrill et al., 2012). Each pre-amplified cell was run for every target
individually and in triplicate. Each cell was run in a CFX96 qPCR machine (BioRad) with a
95°C hot start for 3 minutes, followed by 60 cycles of 95°C for 15 seconds, 57°C for 25 seconds,
and 72°C for 25 seconds. Cycle threshold (Ct) values were determined by the BioRad software.
Treatment with morphine
Male GAD67 GFP+ mice (P15-30) were injected with morphine (Sigma-Aldrich) at 10
mg/kg via intraperitoneal injection either acutely (approximately 24 hours before sacrifice and
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experimentation) or chronically (one dose each day for 7 days with the last dose approximately
24 hours before sacrifice and experimentation).
Drugs
APV, L-NAME, baclofen, DAMGO, and eticlopride were obtained from Tocris and
dissolved in ddH2O to make stock solutions. AM251, CPG 54626, SNAP, and N6-CPA were
obtained from Tocris and dissolved in DMSO to make stock solutions. CNQX was obtained
from Alomone Labs and dissolved in ddH2O. All stock solutions were frozen at –20° C until
dilution into ACSF to give the reported concentrations.
Statistical Analysis
Peak amplitude was analyzed using ClampFit software (Molecular Devices) and
normalized to the average of the last six minutes of baseline. Individual failures were excluded
from minute averages of IPSC amplitude. If a minute was left with fewer than three sweeps, the
entire minute was excluded.
One-way ANOVA analysis was performed on every electrophysiology experiment to
determine if the plasticity was statistically significant comparing baseline to post-conditioning
within every individual experiment. For LTP experiments, baseline was compared to 20-30
minutes postconditioning (as most of the LTP in our studies had a delayed onset). For LTD,
baseline was compared to 10-20 minutes postconditioning.
PPRs were calculated using the average of the last 5 minutes of the baseline with 5-10
minutes postconditioning for both the first and second pulses. PPRs were taken from the
following sets of data: 5Hz control, AM251, CB1 KO, L-NAME, and APV (LTP only).
Statistical significance was calculated using the Wilcoxon ranked sign test, and critical values
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were taken from the Ranked Sign Test Table. Statistical significance was determined using
Student’s T-test in Microsoft Excel.
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Results
We used GAD67-GFP mice to target GABA neurons in the VTA (Tamamaki et al.,
2003), as both GABA and dopamine neurons can display similar electrophysiological
characteristics (Margolis et al., 2006) and GAD65 can co-express with tyrosine hydroxylase
(Gonzalez-Hernandez et al., 2001; Olson & Nestler, 2007). The inhibitory synapse onto VTA
GABA neurons can experience two types of plasticity—LTP or long-term depression (LTD)
(Figure 2.1A). Experiments were individually classified as expressing either LTP or LTD based
on single factor ANOVA analysis (data not shown). Both LTP and LTD were induced in
response to a 5 Hz stimulus (3 minutes or 900 stimuli), though we note that a high frequency
stimulus (2 pulses of 100 Hz) also induced both LTP and LTD (LTP: n = 4, LTD: n = 5; data not
shown). We continued to use a 5 Hz stimulus throughout our study as it gave reliable results and
was deemed to be more physiological. We confirmed that the currents we recorded were
GABAA-mediated, as they were abolished by bath application of the known GABAA antagonists
picrotoxin (100 µM, Figure 2.1B) or bicuculline (30 µM, data not shown). We acknowledge that
IPSCs can also be mediated by the neurotransmitter glycine, which is known to facilitate
neurotransmission at the GABA to dopamine synapse in the VTA (Ye et al., 2004). We found
that the prototypical glycine receptor antagonist strychnine (1 µM) did indeed reduce IPSCs by
~60-70%, but we discontinued this investigation due to the non-specific effects of strychnine
(Hernandes & Troncone, 2009; data not shown). We also saw both LTP and LTD in GFPlittermates of GFP+ animals (Figure 2.1C). In the absence of GAD67-GFP fluorescence, we
confirmed that these cells were GABA cells using a combination of spiking and PCR. To isolate
GABA currents, we eliminated glutamate currents using CNQX (10 µM) in all experiments
described in Figures 2.1-4. Application of CNQX to a recording of all afferents to a VTA GABA
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cell reduces the current to 78.9% ±2.1 of baseline (Figure 2.1D), suggesting that VTA GABA
cells receive most of their input from other GABA cells. Paired pulse ratio (PPR) analysis for
LTP and LTD experiments suggests that both types of plasticity may have a presynaptic
mechanism (Figures 2.1E and 2.1F). We note anecdotally that some GABA cells had notable
failure rates which usually increased following the stimulus protocol, though not all cells
experienced a significant number of failures.
To determine the molecular mechanism of both the LTP and LTD observed at this
synapse, we examined several classic presynaptic mediators of plasticity including the nitric
oxide synthase (NOS) pathway and cannabinoid receptor-1 pathways. While NOS plays an
important role in the mechanism of local GABA to DA plasticity within the VTA (Nugent et al.,
2007; Nugent et al., 2009), we found that it did not alter the induction of either LTP or LTD at
the inhibitory synapse onto VTA GABA neurons as the NOS antagonist L-NAME (200 µM) did
not block either form of plasticity (Figure 2.2A). Similarly, application of the NO donor SNAP
failed to induce plasticity (Figure 2.2B). Furthermore, in the presence of the CB1 antagonist
AM251 (2 µM; Figure 2.2C) or in GFP+ CB1 knock-out animals (Figure 2.2D) significant LTP
and LTD were still exhibited. Chelating calcium with intracellular BAPTA (20 mM) yielded
mixed results and did not definitively block either form of plasticity (n = 5; data not shown).
Similarly, bath application of the selective CB1 agonist WIN55 (10 µM) yielded inconclusive
results (n = 3, data not shown), leading us to rule out CB1 as an important modulator of the
plasticity we observed. Continuing our investigation, both the LTP and LTD were also
independent of D2 dopamine receptor activation, as the D2 antagonist eticlopride (10 µM) did
not block either response (Figure 2.2E). However, surprisingly this LTP appears to be NMDAdependent, as it was blocked by the NMDA receptor antagonist APV (50 µM) when applied
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during baseline and conditioning (Figure 2.2F). This finding is like that of Nugent et al., who
described NMDA-dependent plasticity of GABAergic afferents to VTA dopamine neurons
(2007). Collectively, these data expand our understanding of inhibitory plasticity onto VTA
GABA neurons and suggest a presynaptic mechanism of LTP yet to be fully determined, but
production of a retrograde factor produced from excitatory synaptic activation is likely involved.
However, the previously observed LTD persists in the presence of APV (see Figure 2.2F).
While investigating possible presynaptic mechanisms of plasticity at inhibitory inputs to
VTA GABA cells, we examined the potential role of GABAB receptors. GABAB receptors are
G-protein coupled metabotropic receptors that classically function as autoreceptors (Scanziani,
2000) and could be important molecular targets in pro-cognitive medicine (Serrats et al., 2017).
Edwards et al. identified NAc D1 MSN input to VTA dopamine neurons that was GABAB
mediated (2017), so we used the GABAB agonist baclofen to assess the presence of GABAB at
the synapse of inhibitory inputs to VTA GABA cells. Baclofen (50 µM) strongly depressed
recorded IPSCs (Figure 2.3A). We wondered in GABAB might mediate plasticity at this synapse,
and we found that application of the GABAB antagonist CGP 54626 (2 µM) blocked the
previously observed LTD, while not affecting LTP (Figure 2.3B). These data reveal a previously
unknown synapse at which GABAB mediates plasticity. We attempted to occlude this GABABmediated plasticity by applying a lower concentration of baclofen (1 µM, closer to EC50; Cruz et
al., 2004) throughout the experiment in which a 5 Hz stimulus was used to induce plasticity.
Contrary to our hypothesis, we were unable to occlude plasticity, but instead saw a depression
following 5Hz stimulus in the presence of 1 µM baclofen (Figure 2.3C). We believe that perhaps
constitutive activation of local GABAB receptors by a low concentration of baclofen may
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predispose GABA neurons to experience LTD, similar to the depression evoked in Figure 2.3A
with 50 µM baclofen, only less extreme.
We also investigated the presence of known presynaptic modulators of plasticity at the
inhibitory synapse onto VTA GABA neurons, namely the µ-opioid receptor and the adenosine-1
receptor (A1R). µ-opioid receptor activation is known to depress neurotransmission at
GABAergic synapses though negative coupling with adenylyl cyclase and activation of GO
(Johnson & North, 1992; Williams et al., 2001). Upon acute application of DAMGO (1 µM), a
highly selective and potent µ-opioid receptor agonist, we saw some cells depress (Figure 2.4A),
while another group of cells did not depress and may have slightly potentiated in response to
DAMGO (Figure 2.4A). To obtain these data, DAMGO was applied at the end of another
experiment where 5 Hz stimulus was used to induce plasticity. However, we found each cell's
response to DAMGO to be independent of both plasticity expression and other drugs used in the
experiment. We also tested for the presence and involvement of A1R at the inhibitory synapse
onto VTA GABA neurons and found that all cells tested depressed in response to bath
application of N6-CPA (1 µM), a non-hydrolysable analog of adenosine (Figure 2.4B). These
results are consistent with the findings of Edwards et al., who found that D1 MSN afferents to
VTA GABA and dopamine cells experience depression with N6-CPA application, while local
VTA GABA to dopamine synapses do not (2017). Together these findings highlight roles of µopioid receptors and A1Rs at the inhibitory synapse onto VTA GABA neurons.
We went on to test the effects of chronic morphine administration on the LTP and LTD
we observed at the synapse of inhibitory inputs to VTA GABA neurons. Interestingly, chronic
morphine administration (10 mg/kg via IP injection) for 7 to 9 consecutive days did not block
neither the previously observed LTP nor the LTD (Figure 2.4C). Morphine and other opioids are
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classic presynaptic modulators of neurotransmission (Williams et al., 2001), so understanding
which synapses morphine alters (and which synapses it does not) within the mesolimbic
dopamine circuit may help researchers and clinicians better understand the key neural changes
involved in opiate addiction.
Beyond identifying the mediators of the observed LTP and LTD, another important
question is why we see two distinct types of plasticity at the same synapse. Though different
responses to the same stimulus have been reported before, they often appear to be gradations of
depression that are dependent on the degree of activation or expression levels of necessary
factors like biosynthetic enzymes (McMahon & Kauer, 1997; Péterfi et al., 2012). Conversely,
here we demonstrate two different types of plasticity present at the same synapse. In response to
a 5 Hz stimulus, we observe either LTP or LTD, but have yet to observe (under control
conditions) a situation where LTP and LTD appear to occur simultaneously and result in no net
change at the synapse. We hypothesized that the LTP and LTD we observed arose from different
inhibitory inputs to VTA GABA neurons (Lammel et al., 2012). As previously discussed, two
important sources of GABAergic inputs to the VTA come from the NAc and the LH, and
Bocklisch et al. previously reported LTP of the D1-MSN feedback to VTA GABA cells (2013).
To test the plasticity of LH to VTA inhibitory afferents, we crossed VGAT-IRES-Cre mice to
our GAD67-GFP line and injected AAV2/1-EF1a-DIO-hChR2-mCherry bilaterally into the LH
of GFP+ cross mice to achieve GABA-specific expression of ChR2. We confirmed the injection
site by imaging using a confocal microscope to visualize mCherry infection of cells in the LH
(Figure 2.5A) as well as mCherry+ afferents to GFP+ GABA cells in the VTA (Figure 2.5B). We
recorded optically evoked currents in the VTA and observed only LTD in response to an optical
5 Hz stimulus (Figure 2.5C). This response was likely GABAA-mediated as it was blocked by
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bath application of picrotoxin (100 µM; Figure 2.5D). These results reveal a previously
unknown neural pathway that could be important in processing reward, and consequently could
play a role in the pathology of addiction. Beyond the previously studied roles that this inhibitory
LH to VTA pathway plays in feeding behaviors and compulsive sucrose seeking (Jennings et al.,
2015; Nieh et al., 2015), we highlight a novel form of plasticity and suggest a neural mechanism
by which this LTD may be mediated.
Another potential explanation for the two distinct types of plasticity observed at the
synapse of inhibitory afferents to VTA GABA cells is that there exist subtypes of GABA cells
within the VTA that experience different types of plasticity. Though this hypothesis seemed less
likely in the light our PPR analysis pointing to a presynaptic mechanism for both LTP and LTD,
we investigated this hypothesis by studying the distribution of the GABA synthesis enzymes
GAD67 and GAD65 in VTA GABA neurons and the different plasticity they displayed. GAD67GFP mice were crossed with GAD65-mCherry mice (Jackson Labs) to visualize the coexpression of GAD67 and GAD65 in the VTA. We also stained for tyrosine hydroxylase (TH).
We found co-expression of GAD67 and GAD65, particularly in more dorsal transverse slices of
VTA (Figure 2.6A). We also saw co-expression of GAD65 and TH in select transverse slices
containing more ventral VTA (Figure 2.6B). While we rarely observed GAD67-only cells, we
note a prominent population of GAD65 only cells located medial to traditional VTA (Figure
2.6C). We observed no co-expression of GAD67 and TH (Figure 2.6D). In total we observed
TH+/GAD65+ cells and GAD67+/GAD65+ cells, as well as cells exclusively expressing TH+
and GAD65+. Clearly there is a significant amount of heterogeneity among both dopamine and
GABA populations within the VTA (see also Morales & Margolis, 2017). We used these
GAD67/GAD65 cross mice for whole cell electrophysiology experiments and targeted GAD65
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only cells. We saw a similar pattern of inhibitory plasticity onto VTA GAD65 cells as we saw
with GAD67 cells—inhibitory inputs to these cells express both LTP and LTD (LTP n = 4, LTD
n = 4, data not shown). This suggests that the expression of GAD65 or GAD67 is likely not
predictive of how inhibitory inputs to those GABA cells will experience plasticity. These results
also confirm that GAD65 alone is not a reliable marker of GABA cells, as it can frequently coexpress with TH. This subpopulation of GAD65/TH neurons requires further study.
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Discussion
We herein present data describing mechanisms of plasticity at the inhibitory synapse onto
VTA GABA neurons. Two types of plasticity can be elicited at this synapse in response to a 5
Hz stimulus: LTP or LTD. While these two forms of plasticity appear to be independent of the
CB1 signaling pathway, the NOS system, and D2 receptors, the LTP is dependent on NMDA
signaling, while the LTD requires GABAB activation. We also saw depression in response to the
application of DAMGO and N6-CPA. Chronic morphine administration blocked neither LTP nor
LTD. Finally, we used an optogenetic model to target the LH to VTA GABAergic afferent and
discovered that this synapse experiences LTD in response to an optical stimulus. We are the first
to report LTD at an inhibitory synapse to VTA GABA neurons, and specifically the first to
report LTD at the LH to VTA GABAergic afferent.
As discussed previously, this work follows that of Bocklisch et al. studying inhibitory
inputs to VTA GABA neurons (2013). Their work utilized an optogenetic approach to target
projections from the NAc to the VTA, and they discovered LTP at the inhibitory synapse of D1MSNs to VTA GABA neurons in response to high frequency optical stimulation (trains of 50
Hz). This LTP appeared to be presynaptic, occluded by chronic cocaine, and was dependent on
L-type calcium channels, the D1 receptor, activation of adenylyl cyclase, and the scaffolding
protein Rim1α. We found the LTP in our study to be dependent on NMDA receptor activation,
which could be because we used an electrical stimulus which activated all surrounding neurons
and afferents, as opposed to an optical stimulus which would only activate afferents from the
NAc to the VTA. NMDA receptor activation can modulate plasticity at GABAergic synapses
(Nugent et al., 2007), as well plasticity at nearby excitatory synapses onto both dopamine and
GABA neurons (Bonci & Malenka, 1999; Overton, 1999). Nugent & Kauer suggest that this
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trigger from activity at an excitatory synapse to induce plasticity at a proximal inhibitory synapse
may serve to balance excitation and inhibition within the mesolimbic dopamine circuit (2008).
Further work is necessary to understand if the LTP that we observed in response to a 5 Hz
electrical stimulus is the same LTP observed by Bocklisch et al. in response to an optical
stimulus (2013).
We found the inhibitory LTD onto VTA GABA neurons to be GABAB-mediated.
Edwards et al. found extensive evidence that NAc D1-MSN input to VTA GABA neurons is
GABAA-mediated, while NAc D1-MSN to VTA dopamine neurons is mediated by postsynaptic
GABAB receptors, and that both inhibitory NAc afferents are modulated by the A1R (2017).
This may suggest that GABAB-mediated LTD that we observed may be from another source
besides the NAc, and we did observe optically-induced LTD at the synapse of LH inhibitory
inputs to VTA GABA cells. Metabotropic GABAB receptors have a long history of influencing
both excitatory and inhibitory hippocampal plasticity in many ways (Heaney & Kinney, 2016;
Jappy et al., 2016). There is also a significant body of research demonstrating the GABAB
agonists, such as baclofen, may attenuate certain drug-seeking behaviors in animals (Roberts et
al., 1996; Brebner et al., 2000; Fadda et al., 2003; Cruz et at., 2004; Heaney & Kinney, 2016).
The present study is the first report of GABAB receptor involvement in plasticity of inhibitory
inputs to VTA GABA neurons, which may help to in part explain the results of previous
behavioral studies. GABAB LTD could disinhibit VTA GABA cells and thus increase dopamine
cell activity. Further studies are required to understand if the LTD that we observed via electrical
stimulus is the same LTD that we evoked upon optical stimulation of the LH to VTA inhibitory
pathway.
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The occurrence of LTP or LTD at the same synapse raises questions about why two types
of plasticity can occur and why we have yet to see cells seemingly without plasticity where both
LTP and LTD have occurred simultaneously to give a net null effect. Our two hypotheses to
explain this phenomenon are that (1) inhibitory inputs from different areas of the brain lead to
distinct plasticity outcomes, or that (2) distinct GABA cell subtypes within the VTA experience
inhibitory plasticity differently. We believe that our current data support the first hypothesis
more than the second, though the variety of GAD, VGAT, and TH expression among “GABA”
cells within the VTA should certainly not be overlooked (Morales & Margolis, 2017). We
previously demonstrated the variety of expression in calcium-binding proteins and mGluRs
among VTA GABA and DA neurons (Merrill et al., 2015). Unlike in cortical areas, identification
of calcium-binding proteins and neuropeptides was not very effective at differentiating GABA
cells into specific subtypes. Input/output circuitry may lead end up being the best method of
classifying VTA GABA cells. In addition, our lab has shown mGluR and CB1 dependent
plasticity of excitatory inputs to VTA GABA neurons (Friend et al., 2017). Our current data
present a different story—inhibitory plasticity to VTA GABA cells that is likely CB1independent. Additionally, we herein offer evidence of GABAB-mediated LTD that likely
occurs specifically at inputs from the LH.
Interestingly, our experiments testing µ-opioid receptor modulation using DAMGO did
not point to LTP or LTD cells having inhibitory afferents exclusively expressing the µ-opioid
receptor. Some cells expressing LTP depressed following acute DAMGO exposure (n = 3), while
others also expressing LTP did not (n = 3). Similarly, some cells expressing LTD depressed
following acute DAMGO exposure (n = 3), while others also expressing LTD did not (n = 3).
However, in a recent study by Matsui et al., they found that different inhibitory inputs to VTA
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DA cells (including the RMTg, NAc, and VTA proper) have different sensitivities to opiate
exposure (2014), so we feel it possible that inhibitory inputs to VTA GABA neurons may also
have different responses to acute opiate exposure that vary between inputs. VTA GABA cells
may serve as “switch points” for driving reward and aversion, integrating signals from various
inputs and modulate dopamine activity differentially.
Another important consideration when recording from VTA neurons is the location of
these cells. The VTA is fairly small midbrain nucleus that wraps around the foramen retroflexus
(FR) in transverse slices of mouse brain (Franklin & Paxinos, 2008). More ventrally, the VTA is
located anterior to the FR (though not an anterior as the LH which contains a larger, readily
identifiable nucleus of GABA neurons), and in more dorsal slices is located medial and posterior
to the FR (though not as posterior at the pons, which also contains many GABA cells that are
smaller and more densely packed than VTA GABAs). We recorded from cells that were more
medially located, but still GAD67-GFP+. Our work with GAD65/GAD67 animals suggests that
GAD expression in GABA cells changes moving medial to lateral—more medial cells express
GAD65 only, more laterally GABA cells strongly co-express GAD65 and GAD67, and the most
lateral cells express GAD67 only, though these appear to be rare. We believe that the large
majority of GAD67 GPF+ cells used in Figures 2.1-2.4 of this study were also GAD65expressing. If cells co-expressed GAD65 and TH, they were located more medially and
ventrally. Morales and Margolis report similar patterns of enzyme expression in dopamine
neurons, with the most “classic” dopamine neurons (TH+, VMAT2+, DAT+, and D2+) located
more laterally in the VTA and closer to the substantia nigra pars compacta (SNc), while
dopamine cells of a more transient character (TH+ but VMAT2-, TH+ but DAT-, TH+ but D2-,
TH+ and VGLUT2+) located more medially. A recent study showed circuit specificity between
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the SNc and the dorsal striatum with the medial SNc preferentially receiving afferents from and
projecting to the dorsomedial striatum and the lateral SNc preferentially receiving afferents from
and projecting to the dorsolateral striatum (Lerner et al., 2015). We believe that this type of
location-specific circuitry could also be present between the VTA and NAc and could explain
potential variations between our data and that described by Bocklisch et al. (2013).
While many drugs of abuse act directly on dopamine neurons to increase their firing or
block reuptake, opiates achieve increases in dopamine largely through the mechanism of
disinhibition (Williams et al., 2001). Nugent et al. clearly showed that acute morphine exposure
occludes plasticity of GABAergic inputs to VTA dopamine neurons (2007). Conversely, we
found that chronic morphine altered neither form of plasticity that we observed at the synapse of
inhibitory afferent to VTA GABA cells. Our results more closely align with Edwards et al., who
found that D1 MSNs projecting to the VTA experience cocaine sensitization, but not morphine
sensitization (2017). Morphine has different effects on mesolimbic synapses acutely vs.
chronically, which may be due to phenomena such as tolerance (Bonci & Williams, 1997; Fyfe
et al., 2010). Moreover, we note that morphine is not an exclusive µ-opioid receptor agonist—at
higher concentrations, morphine can also agonize κ- and δ-opioid receptors, but at concentrations
greater than 100 times the dose required to activate µ-opioid receptors (Williams et al., 2001).
Additionally, the κ-opioid receptor-specific agonist U69653 did not weaken IPSCs to VTA
dopamine neurons, unlike the µ-opioid receptor-specific agonist DAMGO which reduced the
amplitude of IPSCs significantly (Matsui et al., 2014). We believe that inputs to VTA GABAs
likely show similar sensitivity to µ- and κ-opioid receptor agonists based on our data showing the
response of these inhibitory inputs to DAMGO.
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The ultimate goal of studying synaptic plasticity in the mesolimbic dopamine circuit is to
further our understanding of the molecular mechanisms responsible for experience-dependent
synaptic plasticity which mediates behavioral responses to reward and aversion. In the future, we
hope to apply this knowledge clinically to aid in the discovery of safe and effective treatments
for those struggling with drug abuse disorder and addiction (Luscher et al., 2015). Opioid abuse
and addiction are serious problems in the United States and around the world (Imtiaz et al., 2014;
Degenhardt et al., 2014). Current treatments are usually only marginally effective and often do
little to decrease the growing problem of opioid addiction, sometimes even exacerbating it
(Schuckit, 2016; Soyka, 2017). A greater understanding of inhibitory plasticity to VTA GABA
neurons is a step toward the development of technology and therapeutic interventions for opioid
addiction.
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Figure 2.1: Inhibitory Afferent to GAD67+ VTA GABA Cells Exhibit Presynaptic LTP or LTD in Response to 5Hz
Stimulus. A) LTP or LTD exhibited at inhibitory inputs to VTA GABA cells in response to 5Hz stimulus (LTP: n =
7, p<0.001 comparing 20-30 minutes post-conditioning to baseline using Student's T-Test; LTD: n = 8, p<0.001
comparing 20-30 minutes post-conditioning to baseline using Student's T-Test). Scale bars in trace insets represent
100 pA and 10 ms. B) GABAA antagonist picrotoxin eliminates IPSCs (n = 11). C) GFP- littermates of GAD67
GFP+ animals also exhibit either LTP or LTD in response to 5 Hz stimulus (LTP: n = 2; LTD: n = 2). D) AMPA
receptor antagonist CNQX (10 µM) reduces current from all afferent to VTA GABAs to 78.9% ±2.1 of baseline (n =
9, p<0.001 comparing baseline to 5-10 minutes after CNQX exposure using Student's T-Test). E) Paired pulse ratio
analysis suggests a presynaptic mechanism for the observed LTP (baseline, 1.20 ± 0.19; after stimulation, 0.79 ±
0.14; n = 13, p<0.001 using Wilcoxon Ranked Sign Test). F) Paired pulse ratio analysis suggests a presynaptic
mechanism for the observed LTD (n = 13, p>0.05 using Wilcoxon Ranked Sign Test).
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Figure 2.2: LTP and LTD Are Independent of the NOS System, the CB1 Signaling Pathway, and D2 Receptors,
while the LTP Is Dependent on NMDA Signaling. A) Both LTP and LTD are still exhibited in the presence of NOS
antagonist L-NAME (200 µM; LTP: n = 4, p<0.001 comparing 20-30 minutes post-conditioning to baseline using
Student's T-Test; LTD: n = 6, p<0.001 comparing 20-30 minutes post-conditioning to baseline using Student's TTest). B) The NO donor SNAP failed to induce plasticity at this synapse (n = 5, p>0.05 comparing 20-30 minutes
post-conditioning to baseline). C) Bath application of CB1 antagonist AM251 (2 µM) failed to block plasticity (LTP
n=4, p<0.001 comparing 20-30 minutes post-conditioning to baseline using Student's T-Test; LTD: n = 7, p<0.001
comparing 20-30 minutes post-conditioning to baseline using Student's T-Test). D) Both types of plasticity are also
still present in GFP+ CB1-/- animals (LTP: n = 6, p<0.001 comparing 20-30 minutes post-conditioning to baseline
using Student's T-Test; LTD: n = 3, p<0.001 comparing 20-30 minutes post-conditioning to baseline using Student's
T-Test). E) Blockade of D2 receptors using eticlopride (10 µM) also failed alter plasticity (LTP: n = 5, p<0.001
comparing 20-30 minutes post-conditioning to baseline using Student's T-Test; LTD: n = 8, p<0.001 comparing 2030 minutes post-conditioning to baseline using Student's T-Test). F) The NMDA receptor antagonist APV (50 µM)
blocked the previously observed LTP (no plasticity group n = 4, p=0.983 comparing minutes 20-30 postconditioning to baseline using Student's T-Test; p<0.001 compared to control LTP in Figure 1A post-conditioning
using Student's T-Test; for LTD: n = 7, p<0.001 comparing baseline to 20-30 minutes post-conditioning using
Student's T-Test). Scale bars in trace insets represent 100 pA and 10 ms.
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Figure 2.3: GABAB Receptors Modulate
Neurotransmission and Specifically LTD
at the Inhibitory Synapse onto VTA
GABA neurons. A) Baclofen (50 µM)
strongly depresses IPSCs onto VTA
GABAs (n = 5). Trace inset shows
baseline (black), baclofen conditioning
(light gray), and washout (dark gray dotdash). B) GABAB antagonist CGP 54626
(2 µM) blocks the previously observed
LTD (no plasticity: n = 5; p=0.2570
comparing 20-30 minutes postconditioning to baseline using Student's
T-Test, p<0.001 compared to control
LTD in Figure 1A post-conditioning
using Student's T-Test; for LTP: n = 7,
p<0.05 comparing baseline to 20-30
minutes post-conditioning using
Student's T-Test). C) A lower
concentration of baclofen (1 µM, closer
to EC50) does not produce occlusion, but
may promote expression of LTD (n = 3,
p<0.05 comparing baseline to 20-30
minutes post-conditioning using
Student's T-Test). Scale bars in trace
insets represent 100 pA and 10 ms.
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Figure 2.4: µ-opioid Receptor Activation
Produces Depression in Some Cells, A1R
Activation Produces Depression in all Cells
tested, and Chronic Morphine Administration
Does Not Block either Form of Previously
Observed Plasticity. A) Acute bath application
of the selective µ-opioid receptor agonist
DAMGO depresses 50% of synapses tested
(depression: n = 6, p<0.05 comparing baseline
to 5-10 minutes following bath application of
drug; no depression: n = 6 p<0.05 comparing
baseline to 5-10 minutes following bath
application of drug). B) Activation of A1R by
N6-CPA application causes all cells tested to
depress significantly (n = 7, p<0.05 comparing
baseline to 5-10 minutes following bath
application of drug). C) Chronic administration
of morphine (10mg/kg via daily IP injection)
did not alter either form of previously observed
plasticity (LTP: n = 5, p<0.05 comparing 10-20
minutes post-conditioning to baseline; LTD: n
= 4; p<0.05 comparing 10-20 minutes postconditioning to baseline).
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Figure 2.5: The Inhibitory (VGAT+) Projection from the LH to VTA GABA Cells Exhibits LTD in Response to a 5
Hz Optical Stimulus. A) We imaged GAD67-GFP expression and ChR2-mCherry expression in the injection site of
surgery mice. B) We were also able to visualize ChR2-mCherry+ axon terminals synapsing onto GAD67-GFP+
cells in the VTA. C) In response to a 5 Hz optical stimulus, the VGAT+ input from the LH to VTA GABAs
depressed significantly (n = 4, p<0.05 comparing baseline to 15-25 minutes post-conditioning). D) This response
was indeed GABAA mediated as bath application of picrotoxin eliminated the current. LH=Lateral Hypothalamus,
3v=3rd ventricle, VMH=Ventromedial hypothalamus. Scale bars in trace inset represent 100 pA and 10 ms.
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Figure 2.6: Heterogeneity of GAD65, GAD67, and TH Expression among VTA GABA and Dopamine Cells. A)
GAD65 (mCherry) and GAD67 (GFP) often co-express, especially in dorsal VTA. B) GAD65 (mCherry) and TH
(blue stain) co-express in ventral VTA. C) GAD65 only cells are found medial to the VTA. D) GAD67 and TH do
not co-express in any part of the VTA. FR=foramen retroflexus, 3v=3rd ventricle, SNc=substantia nigra pars
compacta.
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CHAPTER 3: Expression of mGluR5 Predicts Interneuron Plasticity in the Hippocampal
Stratum Radiatum
Teresa Nufer, Collin Merrill, Lindsey Friend, Michael Jake Peterson,
Zach Hopkins, Jeff Edwards
Abstract
Changes in synaptic strength in hippocampal CA1 pyramidal cells are thought to be
responsible for the acquisition and retention of short-term memory. This plasticity is modulated
by feedforward inhibitory interneurons in the stratum radiatum which are composed of many
subtypes including, among others, parvalbumin-containing axo-axonic cells, calretinincontaining interneuron-selective cells, and cholecystokinin/calbindin positive basket cells. While
radiatum interneurons experience long-term depression (LTD), short-term depression (STD), or
lack of plasticity, it is not known whether these types of plasticity correlate to specific
interneuron subtypes. Using whole cell electrophysiology and real-time quantitative PCR, we
characterized the plasticity expressed by different hippocampal interneuron subtypes in
correlation with their mRNA expression patterns to determine cell subtype using calcium binding
proteins and neuropeptide CCK. We also assessed the expression of endocannabinoid (eCB)
biosynthetic enzymes including diacylglycerol lipase α, N-acyl-phosphatidylethanolaminespecific phospholipase D, and 12-lipoxygenase, as well as metabotropic glutamate receptor
subunits known to mediate plasticity. Cells exhibiting LTD tended to express mRNA for at least
one of the eCB biosynthetic enzymes and the metabotropic glutamate receptor subunit mGluR5.
mGluR5 was not expressed by cells exhibiting STD or no plasticity. Cells that exhibited shortterm depression tended to express mRNA for at least one of the eCB biosynthetic enzymes, but
not mGluR5. This suggests that stratum radiatum interneuron plasticity can be predicted based
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on cell subtype and mGluR expression, and that these different types of plasticity may have some
importance in hippocampal function.
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Introduction
Acquisition and retention of short-term memory are mediated by changes in synaptic
strength between hippocampal neurons. These processes are thought to be mediated by synaptic
plasticity, which is defined as alterations to neurotransmission. Traditionally, increased synaptic
activity strengthens the synaptic connection, termed long-term potentiation (LTP) (Bliss and
Lomo, 1973), while decreased activity weakens the synapse, termed long-term depression (LTD)
(Dudek and Bear, 1992). Both LTP and LTD occur at hippocampal synapses involving
excitatory pyramidal cells and inhibitory interneurons. While the excitatory pyramidal cells
comprise a more homogenous population of neurons, the inhibitory interneurons that modulate
their activity vary widely in morphology (Nissen et al., 2010), expression of calcium-binding
proteins and other marker proteins (Freund and Buzsáki, 1996; Petilla Interneuron Nomenclature
Group, 2008), and stimulus-induced plasticity (Le Duigou et al., 2011). The plasticity of CA1
pyramidal cells is modulated by feedforward inhibitory interneurons in the stratum radiatum
which are composed of many subtypes including, among others, parvalbumin-containing axoaxonic cells, calretinin-containing interneuron-selective cells, and cholecystokinin/calbindin
positive basket cells (Freund & Buzsáki, 1996). While radiatum interneurons exhibit long-term
depression (LTD), short-term depression (STD), or lack of plasticity (McMahon & Kauer, 1997),
little is known about whether these types of plasticity correlate to specific interneuron subtypes.
The variety present among interneurons in the hippocampus raises questions and theories about
their functional purposes, but also makes them difficult to study (Kullman & Lamsa, 2011).
Understanding the specific differences in form and function that exist amongst hippocampal
interneurons will make possible a more complete picture of how plasticity and memory
formation occur on a cellular and molecular level in the brain.
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Comprehending the role of specific interneuron subtypes requires an understanding of the
molecular mechanisms by which synapses change. Endocannabinoid (eCB) lipid signaling
molecules are important and widely used transducers of synaptic plasticity (Chevaleyre et al.,
2006). Made in the postsynaptic neuron from the cell membrane by biosynthetic enzymes, eCB
messengers diffuse retrogradely across synapses to bind G-protein-coupled receptors (GPRs) and
influence presynaptic release of neurotransmitter. For example, the eCB anadamide is made by
n-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) and binds to presynaptic
receptors such as CB1 and TRPV1 (Liu et al., 2006). Similarly, the eCB 2-arachidonylglycerol
(2-AG) is produced by diacylglycerol lipase alpha (DAGLα) and also activates presynaptic
GPRs (Tanimura et al., 2010). Finally, 12-lipoxygenase synthesizes 12-HPETE, yet another
lipid-signaling molecule that can influence synaptic plasticity by acting on the presynaptic cell
(Feinmark et al., 2003). Postsynaptic activation of Type I metabotropic glutamate receptors
(mGluRs) initiates eCB synthesis (Jung et al., 2005; Varma et al., 2001), and Type I mGluRs are
widely expressed in the hippocampus (Baude et al., 1993; Ferraguti et al., 2004).
Le Duigou et al. (2011), Gibson et al. (2008), and Edwards et al. (2012) thoroughly
explored the roles of eCB and Type I mGluR-mediated plasticity at excitatory synapses onto
interneurons in the hippocampus, where type I mGluR activation induces LTD. The interneurons
themselves expressed the enzymes needed to produce eCBs (Merrill et al., 2012) that were
directly involved physiologically in LTD-induction (Péterfi et al., 2012). Their work
demonstrates the postsynaptic involvement of group I mGluRs to activate presynaptic depression
of the synapse. However, it is not known how Type I mGluRs 1 and 5 specifically contribute to
the induction of different types of plasticity (i.e. LTD, STD, or no plasticity) in interneurons of
the CA1 stratum radiatum. Our goal was to demonstrate the relationship between hippocampal
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CA1 stratum radiatum interneuron subtypes and synaptic plasticity, and the relationship between
synaptic plasticity and eCB biosynthetic enzyme and type I mGluR mRNA expression. While
the occurrence of eCB-mediated synaptic plasticity within the hippocampus is well documented,
there is little evidence for the involvement of specific interneuron subtypes in eCB-synaptic
plasticity. Using a combination of whole cell patch clamp electrophysiology and quantitative real
time PCR, we discovered a relationship between the expression of Type I mGluRs and the type
of plasticity that individual interneurons experienced. Expression of mGluR5 seems to predict
LTD in CA1 radiatum interneurons. These data provide further evidence for the importance of
interneuron synaptic plasticity within the hippocampus and the importance of eCB-mediated
signaling in modulation of pyramidal cell activity.

45

Methods
Electrophysiology
All experiments were performed in accordance with Institutional Animal Care and Use
Committee protocols and NIH guidelines for the care and use of laboratory animals. Male
Sprague-Dawley rats P15-30 days old were anesthetized with isoflurane (1.5-2%) and
decapitated. Brains were removed and sectioned coronally on a vibratome at 400 µm using
oxygenated artificial cerebral spinal fluid (ACSF) composed of 119 mM NaCl, 26 mM NaHCO3,
2.5mM KCl, 1 mM NaH2PO4, 2.5mM CaCl2, 1.3mM MgSO4, 11mM glucose, and 400 μM
ascorbic acid. Recordings began at least one hour after cutting while tissue was stored in
oxygenated ACSF composed of 119 mM NaCl, 26 mM NaHCO3, 2.5mM KCl, 1 mM NaH2PO4,
2.5mM CaCl2, 1.3mM MgSO4, and 11mM glucose at room temperature. Inhibitory GABAA
currents were blocked using 100 μM picrotoxin (Abcam) throughout. An Olympus BX51WI
microscope with a 40x water immersion objective was used to visualize hippocampal radiatum
CA1 cells. Interneurons in the CA1 stratum radiatum were patched with a borosilicate glass
pipette (3-6 MΩ) filled with internal solution composed of 117mM cesium gluconate, 2.8mM
NaCl, 20mM HEPES, 5mM MgCl2, and 1 mM QX-314 (Tocris) with pH 7.28 and osmolarity
275–285 mOsm. Recording were made in voltage clamp with cells being held at -65 mV
throughout the experiment. Plasticity was induced using two 100 Hz stimulations, 20 seconds
apart, while still holding the cell at -65 mV in voltage clamp mode. Currents were recorded using
Multiclamp 700B amplifier and digitized with an Axon 1440A digitizer (both from Molecular
Devices, Sunnyvale, CA, USA). Signals were filtered at 4 kHz and recorded using Clampex 10.4
(Molecular Devices) on a personal computer. Electrophysiological data was analyzed using
Clampfit software (Molecular Devices), Microsoft Excel, and Origin 10.8 (OriginLab
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Corporations, Northampton, MA, USA). All p-values were obtained by a Student’s t-test
comparing the 5 minutes before conditioning to 15-20 minutes post conditioning.
PCR
We used the PCR methods as described in our paper Merrill et al., 2015. Briefly, cells
used for PCR analysis were extracted using gentle suction into the recording electrode and then
placed into chilled reverse transcriptase reagents (BioRad) and processed within 2 hours. One
control sample of artificial cerebral spinal fluid was obtained for each slice and used to identify
contamination from extracellular mRNA. Using iScript cDNA Synthesis kit (BioRad), extracted
cells were reverse transcribed to cDNA under the manufacturer’s protocol and cycled in a C1000
Thermocycler (BioRad) at 25°C for 8 min, 42°C for 60 min, and 70°C for 15 min. Following
reverse transcription, each cell was divided into three 5µL aliquots which each received a
different group of 10-fold diluted primers, iQ Supermix (BioRad), and ddH20. We performed
additional no-template-control tests to ensure that there were no primer dimer or hairpin
interactions between primers. The samples were cycled in a C1000 Thermocycler (BioRad)
starting at 95°C for 3 minutes, then 15 cycles of 95°C for 15 minutes, 57°C for 20 seconds, and
72°C for 25 seconds. Final PCR reactions were run in triplicate with individual primers for each
target and specific FAM-TAMRA© (company) probes. The primer and probe sequences were
those used in our previous study (Merrill et al., 2012). Each pre-amplified cell was run for every
target individually and in triplicate. Each cell was run in a CFX96 qPCR machine (BioRad) with
a 95°C hot start for 3 minutes, followed by 60 cycles of 95°C for 15 seconds, 57°C for 25
seconds, and 72°C for 25 seconds. Cycle threshold (Ct) values were determined by the BioRad
software. Targets coming up >20 cycles after 18S were rejected as non-specific false positives.
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Results
To understand how the expression of eCB biosynthetic enzymes, Type I mGluRs, and
interneuron markers is correlated with the induction of specific types of plasticity in individual
cells, we used a combination of whole cell patch clamp electrophysiology and real time qPCR.
After performing a whole cell electrophysiology experiment with high frequency stimulation
(HFS) to induce plasticity, each cell was carefully aspirated into the pipette tip and qPCR was
performed on the genetic material (as described in the Methods) for the targets listed in Table
3.1. This combination of techniques allowed us to describe specific relationships between the
plasticity and mRNA expression patterns in individual cells. We hypothesized that plasticity of
CA1 radiatum interneurons would correlate with specific, previously described interneuron
subtypes (Nissen et al., 2010; Kullman & Lamsa, 2011).
Excitatory synapses onto CA1 radiatum interneurons are known to exhibit different types
of plasticity including long-term depression (LTD), short-term depression (STD), or lack of
plasticity (McMahon & Kauer, 1997). Out of 27 cells, we found that about 13 exhibited LTD
(48.1%), 10 exhibited STD (37%), and 4 did not exhibit plasticity (14.8%) following HFS
(Figure 3.1). Regarding the stratum radiatum interneurons that do not exhibit plasticity following
HFS, these neurons appear to express fewer eCB biosynthetic enzymes, such as 12-Lipo, and are
normally CCK+ basket cells. They typically do not express mGluRs (Figure 3.1 No Plasticity).
Interneurons exhibiting STD following HFS express higher levels of eCB biosynthetic enzymes,
such as 12-Lipo and NAPE-PLD, and can be of various subtypes, including CCK+ basket cells.
Some express mGluR1 (Figure 3.1 Short Term Depression). Finally, stratum radiatum
interneurons exhibiting LTD in response to HFS also typically express eCB biosynthetic
enzymes, but also often express mGluR5 and/or mGluR1 (Figure 3.1 Long Term Depression).
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They can be of many subtypes including CB+ or CCK/CB+ basket cells. When quantifying our
results, we discovered that plasticity is not necessarily an indicator of interneuron subtype, nor is
subtype indicative of plasticity (Table 3.2). While most cells exhibiting no plasticity were CCK
positive, most cells that exhibited STD or LTD were categorized as “uncategorized,” meaning
that we were not able to categorize them into classically recognized interneuron subtypes based
on our PCR results. However, real time qPCR is known to have a high rate (up to 35%) of false
negatives, so it is possible that many, if not all, of our uncategorized cells actually expressed
more interneuron markers than we saw or different markers we did not examine. Despite the high
percentage of uncategorized cells in our sample, we discovered an important relationship
between exhibition of LTD and the expression of mGluR5. Though not all cells exhibiting LTD
expressed mGluR5, every cell that expressed mGluR5 exhibited LTD (Table 3.2). Therefore,
mGluR5 activation could be necessary to produce the eCBs that induce LTD at this excitatory
synapse onto radiatum interneurons. Additionally, mGluR1 appears to only be expressed in cells
that experience LTD or STD (Table 3.2). We also observed that nearly all stratum radiatum
interneuron subtypes appear to produce at least one of the eCB biosynthetic enzymes, regardless
of LTD or STD plasticity. However, these enzymes are not as commonly produced in cells
without plasticity (Table 3.2).
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Discussion
Our data show a potential relationship between the expression of mGluR5 in CA1
radiatum interneurons and the exhibition of LTD: it appears that cells expressing mGluR5
exhibit LTD preferentially over other types of plasticity observed in radiatum interneurons.
Furthermore, nearly all the cells in our study expressed mRNA for eCB biosynthetic enzymes as
demonstrated previously (Merrill et al., 2012), confirming that eCB-mediated plasticity is likely
a common and important mechanism of presynaptic plasticity in the CA1 stratum radiatum of the
hippocampus.
Our recent study demonstrating the differential distribution of eCB biosynthetic enzyme
mRNA (Merrill et al., 2012) is important, as it suggests that eCB-mediated processes do not
occur equally at CA1 stratum radiatum interneuron synapses. In fact, in studies of eCB-mediated
LTD, all interneurons tested did not respond equally to high-frequency stimulation (McMahon
and Kauer, 1997, Gibson et al., 2008). McMahon & Kauer (1997) first described plasticity of
excitatory inputs to hippocampal interneurons in the stratum radiatum. They reported both
bistratified and basket cell morphology among interneurons, though concluded plasticity
expression could not be correlated with interneuron subtype. Our data also supports that
interneuron plasticity is not necessarily cell-type specific, but rather plasticity is determined by
the expression of eCB-biosynthetic enzymes and mGluRs.
Our results also indicate a qualitative effect on plasticity—cells that express mGluR5 can
exhibit LTD while those that do not express mGluR5 do not exhibit LTD. These hippocampal
interneurons also express mRNA for eCB biosynthetic enzymes including DAGLα, which is
expressed in high levels in pyramidal cells and lower levels in interneurons (Péterfi et al., 2012).
Péterfi et al. showed that higher stimulation frequencies and higher concentrations of DHPG
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were required to induce plasticity in interneurons than in pyramidal cells, indicative of a more
quantitative effect. Though we did not test whether increasing the number of stimulus trains
increased the incidence of LTD, we call attention to expression of other eCB biosynthetic
enzymes besides DAGLα in hippocampal interneurons of the CA1 stratum radiatum. NAPEPLD and 12-LO are also frequently expressed in CA1 radiatum interneurons (Merrill et al.,
2012). These postsynaptically-located enzymes produce anadamide and 12-HPETE, respectively,
which can also activate CB1 presynaptically and induce plasticity. Though a quantitative effect
as demonstrated by Péterfi et al. may be real and present, we acknowledge that other eCB
biosynthetic enzymes may be also contributing to the plasticity we observed, either
synergistically or on their own. Additionally, we point out that the qualitative effect we describe
is specific to the Type 1 GPR mGluR5, not an eCB biosynthetic enzyme. Moreover, our data do
not suggest that expression of any particular eCB biosynthetic enzyme correlates with a certain
type of plasticity—NAPE-PLD and 12-LO were expressed in cells exhibiting any type of
plasticity, and DAGLα was present in cells expressing STD or LTD.
The highly heterogeneous nature of hippocampal interneurons has historically made them
difficult to study. Expression of classic interneuron markers can correlate with morphology
and/or plasticity (Freund & Buzsáki, 1996; Nissen et al., 2010; Péterfi et al., 2012), and to
effectively study these interneurons, investigators must carefully define the population they are
studying, often making it challenging to compare the findings of different studies. We concede
that the present study is limited in that we were unable to study cell morphology and correlate
projection patterns to plasticity and Type I mGluR expression. To reduce the incidence of false
negatives in PCR, we pulled the entire cell following the plasticity experiment, making it
prohibitively difficult to also image cells for morphology. We limited our study to interneurons
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of the CA1 stratum radiatum. Our data describes interneurons that likely fall into classically
described subtypes including parvalbumin-containing axo-axonic cells, calretinin-containing
interneuron-selective cells, and cholecystokinin/calbindin positive basket cells (Freund &
Buzsáki, 1996), but subtype does not necessarily correlate with the type of plasticity that a cell
will exhibit. Furthermore, in our study, many neurons where classified as being “uncategorized”
cell types because their expression pattern of interneuron markers did not match classic
descriptions. We recognize that PCR is known to have at least a 35% rate of false negatives as
well as false positives, though ACSF controls were used to decrease the rate of false positives.
We believe that the high rate of uncategorized cells is due to the technical limitations of singlecell, quantitative real time PCR or targets we selected to investigate.
The mechanisms behind the plasticity we observed in excitatory afferents onto CA1
radiatum interneurons have already been explored. While we used a high frequency stimulus to
induce plasticity (two bursts of 100 Hz, similar to Nissen et al., 2010), LTD can also be elicited
using DHPG (Péterfi et al., 2012; Edwards et al., 2012; Le Duigou et al., 2011) or a paired
spiking protocol (Péterfi et al., 2012; Gibson et al., 2008) described TRPV1-dependent, HFSinduced interneuron plasticity in the stratum radiatum. Edwards et al. (2012) and Le Duigou et
al. (2011) describe a DHPG-induced LTD at this synapse that appears to be modulated
presynaptically via the production of a postsynaptically produced retrograde messenger that is
not dependent on CB1, GABAB, or TRPV1. Conversely, Péterfi et al. (2012) describe a paired
spiking-induced plasticity that is dependent on mGluR5, postsynaptic calcium influx, DAG
lipase activity, and CB1, though the cells record from in this study were in the CA1 field, but not
specifically the stratum radiatum. Our data confirm that LTD is inducible at excitatory synapses
onto interneurons in the CA1 radiatum and point to the importance of mGluR5 activation when
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inducing LTD. mGluR1 appears to be less vital for long term plasticity not only in our study, but
also in others (Edwards et al., 2012; Le Duigou et al., 2011; Péterfi et al., 2012). eCB
biosynthetic enzymes appear to be dispersed ubiquitously among CA1 radiatum interneurons,
and eCB synthesis likely plays an important role in hippocampal interneuron plasticity.
Collectively, these data further demonstrate the importance of CA1 stratum radiatum
interneurons in modulation of pyramidal cell activity and the potential of distinct interneuron
populations to differentially modulate learning and memory processing within the hippocampus.
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Table 3.1: qPCR Targets for Each Cell. CA1 radiatum interneurons were run for classic
interneuron markers, eCB biosynthetic enzymes, and Type I mGluRs.
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Table 3.2: Expression of eCB Biosynthetic Enzymes and Type I mGluRs as a Function of
Plasticity and Interneuron Subtype.
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Figure 3.1: Gene Expression and Plasticity Profiles of Stratum Radiatum Interneurons. Approximately 15% of cells
studied displayed no plasticity (n = 4, p>0.05) and many of these expressed mRNA for eCB biosynthetic enzymes,
but not Type I mGLuRs. Next, 37% of interneurons expressed short term depression (LTD) which returned to
baseline approximately 10-15 minutes post-conditioning (n = 10). These cells often expressed mRNA for eCB
biosynthetic enzymes and occasionally for mGluR1. Finally, nearly 50% of cells displayed long term depression (n
= 13, p<0.05 between baseline and 10-15 minutes post-conditioning). These cells always expressed mRNA for at
least one eCB biosynthetic enzyme and often for Type I mGluRs, especially mGluR5.
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CHAPTER 4: Conclusion
Synaptic plasticity is amazing. Our brains are wired with individualized methods of
coding information so that we can learn, remember, and survive. We engage in hundreds of
activities and tasks every day that literally shape our brains. Even the way that we think about
ourselves and our surroundings can alter who we are on a neurological level.
Comprehending the molecular mechanisms of plasticity is key to understanding
behavioral modifications. We understand uniqueness and creativity in the brain as we learn about
synaptic plasticity. We understand the neural roots of many brain pathologies as we learn about
plasticity. Drug addiction, mental illness, traumatic brain injury, aging, stress, and many other
states of mind and body alter synaptic plasticity. From the LTP-like changes that form memories
to the mechanisms of stress-induced hippocampal atrophy, clearly the physiology of our brains
determines our behavior. Psychologists should find it difficult to talk about behavior without
talking the brain, just as neuroscientists should remember the changes in behavior that result
from changes in neural physiology.
The projects presented here have focused on how synaptic plasticity functions at specific
synapses in the VTA and hippocampus. We highlight a novel form of plasticity at the synapse of
inhibitory inputs to VTA GABA cells. We also report on how interneurons of the hippocampus
express eCB biosynthetic enzymes and mGluRs in order to exhibit neural plasticity. Practically,
these studies expand our understanding of the how synapses are modified on a cellular level and
how that modulation can vary from cell to cell. Our results are unique in that we report multiple
forms of plasticity occurring at the same synapses. We believe that these findings highlight the
heterogenous character of GABAergic interneurons as well as the potential for GABA
modifications to influence behavior in specialized ways. We speculate that GABA cells may act
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as “switch points,” where neural outcomes are summated, measured, and executed to ultimately
influence behavior.
One important behavioral consequence of plasticity in the mesolimbic dopamine circuit is
addiction. Normally, this circuit helps us discern pleasurable, species-perpetuating stimuli from
aversive, harmful stimuli, but addiction is the sustained disruption of this processing center such
that an individual can no longer process reward normally. This disruption is the result of an
artificial increase in dopamine release, commonly caused by drugs of abuse. Behaviorally,
addiction is manifested by cravings, withdrawals, and compulsive drug-seeking behavior. A
picture of the true pathology of addiction is slowly emerging as various synapses are studied at
different phases of addiction using sophisticated techniques. Addiction involves changes to VTA
dopamine and GABA neurons, as well as their efferents and afferents. My contribution to the
field of molecular addiction research helps to paint a more complete picture of the effects that
drugs of abuse have (and don’t have) on the brain. Using our knowledge of molecular plasticity
mechanisms within the mesolimbic dopamine circuit, I hope that a pharmacological treatment for
narcotic addiction will one day become available.
In conclusion, inhibitory neurons in the brain have long been underappreciated and
understudied. However, new research argues that inhibitory GABA neurons may be the hidden
ringmasters who orchestrate neural and behavioral outcomes. This study of GABA neurons in
the brain contributes to the growing body of evidence suggesting the vital role of inhibitory
neurotransmission in modulating both synaptic plasticity and behavior.
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